Brentuximab Vedotin effects on prognosis of refractory and relapsed peripheral T-Cell lymphoma: a systematic review. Rev Med Saude Brasilia [Internet]. 2019 Jan. 5 [cited 2026 Sep. 27];7(2). Available from: https://ojs-test.siteworks.com.br/index.php/rmsbr/article/view/9251